Case Details
- Citation: [2024] SGCA 55
- Title: Iskandar bin Jinan v Public Prosecutor and another appeal
- Court: Court of Appeal of the Republic of Singapore
- Date of decision: 28 November 2024
- Date of hearing: 8 October 2024
- Judgment length: 71 pages; 19,164 words
- Judges: Sundaresh Menon CJ, Tay Yong Kwang JCA and Steven Chong JCA
- Appellant (CCA 18/2023): Iskandar bin Jinan
- Appellant (CCA 6/2024): Mohd Farid Merican bin Maiden
- Respondent: Public Prosecutor
- Criminal appeal numbers: Criminal Appeal No 18 of 2023; Criminal Appeal No 6 of 2024
- Underlying criminal case: Criminal Case No 51 of 2023
- Legal area: Criminal Procedure and Sentencing — Sentencing
- Core sentencing framework issue: Proper understanding and calibration of the Sentencing Advisory Panel’s Guidelines on Reduction in Sentences for Guilty Pleas (“PG Guidelines”) in drug trafficking and drug importation contexts
- Statutes referenced: Misuse of Drugs Act (Cap 185, 2008 Rev Ed) (“MDA”)
- Cases cited (as provided): [2017] SGDC 247; [2018] SGDC 319; [2019] SGHC 151; [2020] SGDC 179; [2020] SGHC 203; [2021] SGCA 32; [2021] SGDC 273; [2021] SGDC 40; [2021] SGDC 89; [2021] SGHC 111
Summary
In Iskandar bin Jinan v Public Prosecutor and another appeal ([2024] SGCA 55), the Court of Appeal addressed how the Sentencing Advisory Panel’s Guidelines on Reduction in Sentences for Guilty Pleas (“PG Guidelines”), which came into effect on 1 October 2023, should be applied in the specific context of drug trafficking and drug importation offences. The appeals arose from guilty pleas taken at an early stage, with both appellants receiving lengthy global sentences after conviction for multiple MDA offences.
The Court of Appeal clarified that the PG Guidelines are advisory and non-binding, and therefore should not be applied rigidly or as a “one size fits all” formula. Instead, the court must calibrate the reduction for a guilty plea by taking into account the nature of the offence, the sentencing framework for drug trafficking/importation, and the relevant public policy considerations embedded in Parliament’s sentencing design. The Court also rejected approaches that would mechanically cap reductions at overly high percentages without sufficient regard to the drug sentencing benchmarks.
What Were the Facts of This Case?
The appeals concerned two accused persons, Iskandar bin Jinan (“Iskandar”) and Mohd Farid Merican bin Maiden (“Farid”), both of whom pleaded guilty to multiple drug-related charges under the Misuse of Drugs Act (Cap 185, 2008 Rev Ed). The charges in the underlying Criminal Case No 51 of 2023 were dealt with together at first instance, and the appellants were sentenced to global terms of imprisonment reflecting the seriousness of their conduct and their antecedents.
Iskandar (aged 52 at the time of the offences) pleaded guilty to three principal charges. First, he was convicted of trafficking in not less than 14.99g of diamorphine under s 5(1)(a) read with s 33(1) of the MDA. Second, he was convicted of having in his possession for the purposes of trafficking not less than 82.4g of methamphetamine under s 5(1)(a) read with s 5(2), punishable under s 33(4A). Third, he was convicted of consuming methamphetamine under s 8(b)(ii), punishable under s 33(4). In addition, he consented to three other drug-related charges being taken into consideration for sentencing (“TIC Charges”), involving possession for trafficking and possession offences relating to diamorphine and methamphetamine.
Farid (aged 51 at the time of the offences) pleaded guilty to three principal charges. He was convicted of abetting by engaging in conspiracy with Iskandar to traffic in not less than 14.99g of diamorphine under s 5(1)(a) read with s 12 and punishable under s 33(1). He was also convicted of consuming a specific synthetic cannabinoid-related substance under s 8(b)(i), punishable under s 33(4). Finally, he was convicted of having in his possession for the purposes of trafficking not less than 277.14g of vegetable matter and not less than 392.8g of colourless liquid analysed to contain 5-fluoro-MDMB-PICA (or a fluoro positional isomer) under s 5(1)(a) read with s 5(2) and punishable under s 33(4A). Farid similarly consented to two additional consumption-related TIC Charges involving related fluoro positional isomers.
Both appellants had been in remand since their arrest on 22 May 2019. The Court of Appeal noted that the appellants’ drug trafficking antecedents were relevant to sentencing, and that Iskandar had four previous drug trafficking convictions over three occasions. The presence of antecedents and the multiplicity of offences meant that the sentencing exercise required careful calibration, particularly where the appellants sought reductions on account of their early guilty pleas under the PG Guidelines.
What Were the Key Legal Issues?
The central issue in both appeals was the correct understanding and application of the PG Guidelines in the context of drug trafficking and drug importation offences. Although the appellants pleaded guilty at an early stage and therefore sought the benefit of sentence reductions, the Court of Appeal had to determine how far the PG Guidelines could be applied without undermining the established sentencing benchmarks and public policy considerations for serious drug offences.
More specifically, the Court of Appeal had to decide whether the PG Guidelines provide an appropriate framework to determine the extent to which a sentence might be reduced on account of a plea of guilt in drug trafficking and drug importation cases. This required the court to consider the relationship between (i) the utilitarian and remorse-based rationales for guilty-plea discounts, and (ii) the existing sentencing framework for drug trafficking/importation offences, which already accounts for deterrence, incapacitation, and the gravity of drug supply and importation.
A further issue concerned calibration: how the maximum reduction percentages contemplated by the PG Guidelines should be adjusted for drug trafficking/importation offences. The Court of Appeal examined competing approaches, including proposals for maximum reductions of up to 30% and up to 15%, and evaluated whether such caps were workable or whether they produced conceptual or practical problems when applied to drug trafficking/importation sentencing bands.
How Did the Court Analyse the Issues?
The Court of Appeal began by situating the guilty plea discount within broader sentencing principles. It emphasised that the decision to plead guilty is ultimately made by the accused person, and that legal principles have long recognised the mitigatory value of a plea of guilt. However, the court observed that different decisions have accorded different weight to guilty pleas depending on factors such as the stage at which the plea is taken, the strength of the evidence, the nature of the offence, and the degree of remorse shown. This variability, the Court noted, can lead to perceived inconsistency in sentencing outcomes.
Against that background, the Court explained the purpose of the Sentencing Advisory Panel and the PG Guidelines. The PG Guidelines were designed to promote greater consistency and transparency by providing publicly available guidance on sentence reductions for guilty pleas. Importantly, the Court underscored that the PG Guidelines are advisory and non-binding. The guidelines recognise that early guilty pleas can spare victims and witnesses from the need to testify and can save public resources for law enforcement, prosecution, and the judiciary. Accordingly, earlier pleas can justify larger reductions, up to a maximum percentage stated in the PG Guidelines.
However, the Court of Appeal cautioned against treating the PG Guidelines as a rigid formula. Parliament, in enacting mandatory or structured sentencing for drug offences, would have taken into account public policy considerations specific to those offences. Therefore, a “one size fits all” approach is inappropriate. The Court held that the court’s task is to calibrate the appropriate reduction by considering all relevant considerations, including the nature of the offence and the sentencing benchmarks for drug trafficking/importation.
In addressing calibration, the Court analysed the competing rationales for guilty-plea discounts, including a “utilitarian approach” (focused on efficiency and resource savings) versus a “remorse-based approach” (focused on personal mitigation). The Court treated these rationales as relevant but not determinative in isolation, especially in drug trafficking/importation cases where the sentencing framework is driven by deterrence and the seriousness of the conduct. The Court also emphasised that the guilty plea should be accounted for in a separate step within the sentencing framework, rather than being absorbed in a way that distorts the baseline sentencing analysis.
The Court then turned to the existing sentencing framework for drug trafficking and drug importation offences. It considered how indicative starting bands and indicative aggregate bands operate in such cases, and how a guilty plea reduction should be applied to those bands. The Court examined proposals that would apply a maximum reduction of up to 30% or up to 15%, and identified problems with each. In particular, it found that applying a maximum reduction of 30% could create difficulties because it may be too large relative to the structure of drug sentencing bands, potentially leading to outcomes that do not reflect the intended balance between mitigation and the gravity of drug trafficking/importation. Similarly, a maximum reduction of 15% (as applied by the judge below) was also problematic, suggesting that it did not adequately reflect the calibrated role of the guilty plea discount within the drug sentencing framework.
After comparing the proposed frameworks and analysing their drawbacks, the Court of Appeal concluded that the correct calibration for drug trafficking and drug importation offences is a maximum reduction of up to 10%. The Court reasoned that a 10% cap avoids the problems that “plague” the higher caps and better preserves the integrity of the drug sentencing benchmarks while still giving effect to the mitigatory value of early guilty pleas. The Court further explained that reductions should be applied across subsequent stages under the PG Guidelines, and that the reduction should be nearer to the maximum within each stage where the timing and circumstances justify it.
The Court also addressed the “public interest exception” under para 13(b) of the PG Guidelines. This exception recognises that in certain circumstances, the public interest may require a lesser reduction than would otherwise be available. The Court’s discussion indicates that even where the accused pleads early, the court must still consider whether the offence’s public policy dimension warrants limiting the guilty plea discount.
Finally, the Court applied the calibrated PG Guidelines to the present appeals. It treated the calibration as a principled adjustment rather than a modification of the PG Guidelines themselves. The Court’s approach reflects a consistent theme: guidelines are tools for transparency and consistency, but the sentencing court retains responsibility to ensure that the reduction for a guilty plea fits the statutory and policy context of the offence.
What Was the Outcome?
The Court of Appeal dismissed Iskandar’s appeal (CCA 18/2023). In doing so, it upheld the sentencing approach taken at first instance and did not find sufficient basis to reduce Iskandar’s global sentence further in light of the proper calibration of the PG Guidelines for drug trafficking and drug importation offences.
By contrast, the Court allowed Farid’s appeal (CCA 6/2024) in part, reducing Farid’s global sentence from 31 years’ imprisonment to 30 years’ imprisonment on a point of principle. The reduction was grounded in the correct application of the PG Guidelines as calibrated for drug trafficking/importation offences, demonstrating that while the guilty plea discount is real, it must be applied within a structured and offence-sensitive framework.
Why Does This Case Matter?
This decision is significant for practitioners because it provides authoritative guidance on how the PG Guidelines should be operationalised in serious drug cases. While the PG Guidelines are intended to enhance consistency, Iskandar clarifies that the maximum percentage reductions contemplated by the guidelines cannot be applied mechanically across all offence categories. Instead, courts must calibrate the reduction to preserve the statutory sentencing architecture for drug trafficking and importation offences.
The Court’s adoption of a maximum reduction of up to 10% for drug trafficking and drug importation offences is likely to become a key benchmark in sentencing submissions and appellate arguments. Defence counsel seeking guilty plea discounts in such cases will need to frame their submissions around the calibrated cap and the stage/timing considerations within the PG Guidelines, while the Prosecution can rely on the calibrated approach to resist overly large discounts that would undermine deterrence and public policy.
For law students and researchers, the case also illustrates the Court of Appeal’s method: it treats guidelines as advisory instruments, reconciles guilty-plea mitigation with offence-specific sentencing frameworks, and explicitly analyses why certain percentage caps create conceptual or practical difficulties. This makes the judgment a useful reference point for understanding the interaction between sentencing guidelines, statutory policy, and appellate review of sentencing discretion.
Legislation Referenced
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed) (“MDA”)
Cases Cited
- [2017] SGDC 247
- [2018] SGDC 319
- [2019] SGHC 151
- [2020] SGDC 179
- [2020] SGHC 203
- [2021] SGCA 32
- [2021] SGDC 273
- [2021] SGDC 40
- [2021] SGDC 89
- [2021] SGHC 111
Source Documents
This article analyses [2024] SGCA 55 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.